Activity value 77france Buyer&Supplier,Last transaction date:
2026-04-10Address: 43 rue des eauxza du plaguebp 80307vitre cedex
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for eurimex pharma from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 1 transactions, with a transaction quantity of 0 and a transaction weight of 678.93.
1fk farma
pakistanbuyer,they trade on 2013-12-12
10.01%
>
2sce sante
united statesbuyer,they trade on 2009-03-25
10.01%
>
3nampharm pty ltd
namibiabuyer,they trade on 2026-04-10
10.01%
>
Products
Total 1
ProductsTransactionsPerDetail
medicine 1100%>
Trading Area
Total 3
AreaTransactionsPerDetail
namibia10.01%>
pakistan10.01%>
united states10.01%>
Port statistics
Total 2
Port NameTransactionsPerDetail
auh10.01%>
le havre10.01%>
eurimex pharma is france Buyer&Supplier,
and primarily engages in the import and export business of products such as medicine.
According to the 52wmb.com global trade database, as of 2026-04-10, the company has completed 12523 international trades,
with its main trading regions covering namibia,pakistan,united states etc.
often transported via auh,port le havre etc,
and its main trading partners are fk farma,sce sante,nampharm pty ltd.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on eurimex pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.